Literature DB >> 32985953

Head Mild Hypothermia Exerts a Neuroprotective Role in Ischemia-Reperfusion Injury by Maintaining Glial Glutamate Transporter 1.

Dongyang Ma1, Qi An1, Zhiqiang Zhang1, Qinghu Bian1, Yanan Li1, Yanli Li1, Shan Zhang1.   

Abstract

Stroke is the second leading cause of death worldwide; nevertheless, its pathological mechanism still remains unclear. Besides, there is an urgent need to find new effective treatment strategies for patients with stroke. Hypothermia therapy is widely used in clinical as a neuroprotective strategy practice. However, the exact mechanism is not fully understood. In this study, we examined the effects of hypothermia on glial glutamate transport-1 (GLT-1) and the extracellular glutamate concentration ([Glu]e) in cerebral ischemia-reperfusion insult rats. Our results revealed that cerebral brain ischemia-reperfusion caused the decrease of GLT-1 and Bcl-2, the increase of Bax and [Glu]e, and caused neuron loss. On the contrary, head mild hypothermia (HMH) for 2 hours alleviated the abovementioned effects and exerted neuroprotection. In the hypothermia group, pretreatment with dihydrokainate, a functional antagonist of GLT-1 by lateral ventricle injection partly reversed the abovementioned effect of HMH. Our results suggest that HMH could exert a neuroprotective role by maintaining GLT-1 and reducing the excitotoxicity of [Glu]e during ischemia-reperfusion insult in rats.

Entities:  

Keywords:  glutamate transport; ischemia–reperfusion; mild hypothermia; neuroprotection

Mesh:

Substances:

Year:  2020        PMID: 32985953     DOI: 10.1089/ther.2020.0012

Source DB:  PubMed          Journal:  Ther Hypothermia Temp Manag        ISSN: 2153-7658            Impact factor:   1.286


  1 in total

1.  Neuroprotective Effect of Moxibustion on Cerebral Ischemia/Reperfusion Injury in Rats by Downregulating NR2B Expression.

Authors:  Zhong Di; Qin Guo; Quanai Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-25       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.